dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Garrido‑Cumbrera, M. |
dc.contributor.author | Santos‑Lasaosa, S. |
dc.contributor.author | Aguirre‑Vazquez, M. |
dc.contributor.author | Correa‑Fernández, J. |
dc.contributor.author | Colomina, I. |
dc.contributor.author | Pozo Rosich, Patricia |
dc.contributor.author | Irimia, Pablo |
dc.date.accessioned | 2021-11-29T10:46:58Z |
dc.date.available | 2021-11-29T10:46:58Z |
dc.date.issued | 2021-04-15 |
dc.identifier.citation | Irimia P, Garrido-Cumbrera M, Santos-Lasaosa S, Aguirre-Vazquez M, Correa-Fernández J, Colomina I, et al. Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas. Sci Rep. 2021 Apr 15;11:8286. |
dc.identifier.issn | 2045-2322 |
dc.identifier.uri | https://hdl.handle.net/11351/6618 |
dc.description | Neurociència; Psicologia |
dc.description.sponsorship | This study has been supported by Novartis Farmacéutica Spain. |
dc.language.iso | eng |
dc.publisher | Nature Research |
dc.relation.ispartofseries | Scientific Reports;11 |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Migranya - Epidemiologia - Espanya |
dc.subject | Discapacitats - Psicologia |
dc.subject.mesh | Migraine Disorders |
dc.subject.mesh | /epidemiology |
dc.subject.mesh | Spain |
dc.subject.mesh | Disabled Persons |
dc.title | Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1038/s41598-021-87352-2 |
dc.subject.decs | trastornos migrañosos |
dc.subject.decs | /epidemiología |
dc.subject.decs | España |
dc.subject.decs | personas con discapacidad |
dc.relation.publishversion | https://doi.org/10.1038/s41598-021-87352-2 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Irimia P] Department of Neurology, Clínica Universidad de Navarra, Av. Pío XII 36, 31008 Pamplona, Spain. Navarra’s Health Research Institute (IDISNA), Pamplona, Spain. Headache Study Group of the Spanish Neurological Society (GECSEN), Pamplona, Spain. [Garrido-Cumbrera M, Correa-Fernández J] Health and Territory Research (HTR), Universidad de Sevilla, Sevilla, Spain. [Santos-Lasaosa S] Headache Study Group of the Spanish Neurological Society (GECSEN), Pamplona, Spain. Department of Neurology, Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain. Instituto de Investigación Sanitaria IIS Aragón, Zaragoza, Spain. [Aguirre-Vazquez M] Novartis Farmacéutica Spain, Barcelona, Spain. [Colomina I] Spanish Patient’s Association of Migraine and Headache (AEMICE), Madrid, Spain. [Pozo-Rosich P] Headache Study Group of the Spanish Neurological Society (GECSEN), Pamplona, Spain. Unitat de Cefalea, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca en Cefalea (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain |
dc.identifier.pmid | 33859216 |
dc.identifier.wos | 000641844600042 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |